ISMRM & ISMRT Annual Meeting & Exhibition • 10-15 May 2025 • Honolulu, Hawai'i

ISMRM & ISMRT 2025 Annual Meeting & Exhibition

Digital Poster

Next Frontiers in Breast MRI

Navigation: Back to Meeting HomeBack to Meeting Home Navigation: Back to Program-at-a-GlanceBack to the Program-at-a-Glance

Next Frontiers in Breast MRI
Digital Poster
Body
Monday, 12 May 2025
Exhibition Hall
17:00 -  18:00
Session Number: D-51
No CME/CE Credit

 
Computer Number: 17
2118. Nomogram Based on Breast MRI for Predicting Treatment Decisions in HR-Positive Breast Cancer
m. Sheng, l. zhang
the Affiliated 2 Hospital of Nantong University, Nantong, China
Impact: This MRI-based nomogram enables personalized treatment for HR-positive breast cancer , thus offering a non-invasive, cost-effective approach for recurrence risk stratification and extended endocrine therapy decisions.
 
Computer Number: 18
2119. Earlier response monitoring strategy of breast cancer with longitudinal multiparametric MRI follow neoadjuvant chemotherapy
Y. Li, J. Guo, Y. Xue, L. Xie, H. Lu
Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
Impact: This study is highly impactful, as it demonstrates that MRI biomarkers can dynamically predict the response to NAC, with the combination of kinetic and diffusion parameters enabling early prediction of treatment response.
 
Computer Number: 19
2120. Super Voxel Clustering for DCE-MRI Pharmacokinetic Analysis and the Effect on Prediction of Breast Cancer Therapy Response
B. Moloney, A. Tudorica, D. Biswas, A. Kazerouni, J. Holmes, S. Partridge, W. Huang, X. Li
Oregon Health & Science University, Portland, United States
Impact:

Use of SVs to stabilize advanced DCE-MRI PK models may potentially improve accuracy of estimated Ktrans and its predictive performance for BC response to NAC.

 
Computer Number: 20
2121. Radiomics analysis of contrast-free synthetic MRI and ADC for early predicting neoadjuvant chemotherapy response in breast cancer
Y. Zhang, S. Du, L. Xie, L. Zhang
The Fourth Affiliated Hospital of China Medical University, Shenyang, China
Impact: Multiparametric SyMRI and ADC, as noncontrast sequences, have the potential to early predict NAC response in radiomics analysis, thus reducing the need for repeated contrast agent injections during treatment.
 
Computer Number: 21
2122. Accelerated High-Resolution T1- and T2-weighted Breast MRI with Deep Learning Super-Resolution Reconstruction
N. Mesropyan, C. Katemann, A. Isaak, O. Weber, J. Peeters, A. Lakghomi, J. Luetkens
University Hospital Bonn , Bonn, Germany
Impact: Deep learning reconstruction algorithm for denoising with compressed sensing and resolution upscaling reduces acquisition time and improves image quality for dynamic contrast-enhanced T1w and T2w breast MRI.
 
Computer Number: 22
2123. Patient comfort in supine breast MRI using a wearable RF coil — preliminary analysis of questionnaires developed in a Citizen Science project
L. Nohava, E. Laistler, R. Frass-Kriegl
High Field MR Center, Center for Medical Physics and Biomedical Engineering, Medical University of Vienna, Vienna, Austria
Impact: The study supports a patient-centered, supine breast MRI approach, enhancing comfort, especially for individuals facing physical constraints. This has potential implications for broader patient inclusion and improved compliance in breast cancer diagnostics.
 
Computer Number: 23
2124. Relative SNR Measurement with Supine versus Prone Positioning in Breast MRI
J. Hess, C. Moran, P. Shah, J. Vincent, F. Robb, B. Daniel, B. Hargreaves
Stanford University, Stanford, United States
Impact: Breast MRI has emerged as a key component to breast cancer imaging. However, the prone setup is uncomfortable for many patients. Being able to scan in supine with potential SNR benefits would allow for a robust supine breast MRI protocol.
 
Computer Number: 24
2125. Automated assessment of background parenchymal enhancement on breast MRI: Impact on breast cancer risk in a matched cohort study
H. Yoen, S. Kim, S-O Kim, S. M. Ha
Seoul National University Hospital, Seoul, Korea, Republic of
Impact: With more robust measurement, BPE alongside with clinical risk factors and breast density could enhance breast cancer risk assessment. This could help optimize breast screening strategy through a multimodal approach.
 
Computer Number: 25
2126. Cluster analysis of quantitative ultrafast DCE-MRI for DCIS grading and upgrading without tracing lesion region-of-interest
Z. Ren, X. Fan, H. Shim, H. Abe, K. Kulkarni, G. Karczmar
University of Chicago, Chicago, United States
Impact: K-means clustering analysis of ultrafast DCE-MRI can help identify DCIS, differentiate between low- and high-grade DCIS and identify invasive potential, and facilitate personalized treatment by guiding decisions on aggressive treatment versus surveillance for breast cancer patients.
 
Computer Number: 26
2127. Ultra-low field (6.5 mT) Magnetic Resonance Breast Imaging : A Pilot Study
S. Shen, N. Koonjoo, S. Ogier, M. Saksena, L. Lamb, J. Camacho, K. Keenan, M. Rosen
Massachusetts General Hospital, Charlestown, United States
Impact: This preliminary work demonstrates that ULF magnetic breast imaging is feasible and may be a viable option for breast cancer diagnosis and screening.
 
Computer Number: 27
2128. Advancing Radiogenomics: MRI-Guided Identification of Novel Breast Cancer Molecular Subtypes
Q. LAI, X. TENG, X. ZHANG, J. ZHANG, T. LI, J. CAI, G. REN
The Hong Kong Polytechnic University, HongKong, China
Impact: This study advances radiogenomics by demonstrating functional MRI-guided identification of new breast cancer subtypes, highlighting its potential in clinical applications.
 
Computer Number: 28
2129. Diagnostic Value of IVIM-Based Virtual MR Elastography Compared with Real MR Elastography in Breast Lesions
N. Zhou, J. Li, M. Chen, Y. Zhou, Y. Wang, Z. Han, W. Wang, Y. Jiang
Medical imaging department,First Affiliated Hospital of Kunming Medical University, Kunming, China
Impact: IVIM-based vMRE shows potential as a non-invasive alternative to rMRE for breast lesion diagnosis, offering broader applicability in patient care by enhancing diagnostic accessibility, especially for cases unsuited to traditional rMRE.
 
Computer Number: 29
2130. Comparative Analysis of Image Quality in Breast DWI at 3.0T: DL- RESOLVE vs. Standard RESOLVE
Z. Laraib, M. Tsarouchi, Z. Cevval, M. Maas, E. Weiland, G. Thoermer, R. Mann
Radboudumc, Nijmegen, Netherlands
Impact: DL-RESOLVE leverages advanced deep learning techniques to provide contrast-free breast MRI with better image quality, reduced artifacts, and shorter acquisition time. This innovative approach enhances diagnostic accuracy and efficiency, making it a promising tool for clinical breast imaging. 
 
Computer Number: 30
2131. Optimizing DCE-MRI Interpretation to Improve Tumor Extent Assessment and Margin Negativity in Breast-Conserving Surgery for Lobular Carcinoma
N. Cho, H. Yoen
Seoul National University Hospital, Seoul, Korea, Republic of
Impact: Incorporating both mass and non-mass enhancements in the delayed phase of DCE-MRI could improve preoperative assessment accuracy for lobular carcinoma, helping surgeons achieve negative resection margins and potentially reducing reoperation rates in breast-conserving surgery.
 
Computer Number: 31
2132. Quantifying Ultrafast MR Contrast as a Function of Lesion Size: Silico Simulation, 3D Printed Phantom, and Clinical MR Images
Z. Long, E. Macdonald, S. Robertson
Duke University, Durham, United States
Impact: This study aims to enhance ultrafast breast MRI by demonstrating the diagnostic value of employing isotropic spatial resolution to minimize contrast loss from partial volume effects, potentially allowing better diagnosis of small and early-enhancing lesions, ultimately reducing unnecessary biopsies.
 
Computer Number: 32
2133. Classification of HER2-zero and HER2-low and Prediction of Progression in Triple Negative Breast Cancer Using MRI Features
J. Zhou, Y. Zhang, Y-L Liu, J-H Chen, M. Wang, M-Y Su
The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China
Impact: TNBC had negative ER, PR, and HER2, which was defined as immunohistochemical staining 0, 1+, or 2+ with negative FISH, but currently, HER2-low may receive anti-HER2 drug conjugates. Finding imaging biomarkers may help in precision treatment and understanding progression risk.
Similar Session(s)

Navigation: Back to Meeting HomeBack to Meeting Home Navigation: Back to Program-at-a-GlanceBack to the Program-at-a-Glance

The International Society for Magnetic Resonance in Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.